vs
ARTIVION, INC.（AORT）とRepay Holdings Corp（RPAY）の財務データ比較。上の社名をクリックして会社を切り替えられます
ARTIVION, INC.の直近四半期売上が大きい（$116.0M vs $78.6M、Repay Holdings Corpの約1.5倍）。ARTIVION, INC.の純利益率が高く（2.1% vs -178.3%、差は180.4%）。ARTIVION, INC.の前年同期比売上増加率が高い（19.2% vs 0.4%）。Repay Holdings Corpの直近四半期フリーキャッシュフローが多い（$23.2M vs $-7.9M）。過去8四半期でARTIVION, INC.の売上複合成長率が高い（9.1% vs -1.3%）
Artivion, Inc.は心血管移植向けの極低温保存した人体組織の流通、及び医療機器の開発を行う医療企業です。同社の製品には、余分な細胞物質と抗原を除去する処理を施した人間の心臓弁、手術用接着剤BioGlueなどがあり、臨床現場のニーズに応えています。
Repay Holdings Corpは北米を主要市場とする決済テクノロジー企業で、小売、医療、自動車サービス、電子商取引などの業種の企業向けに、クレジット・デビットカード決済処理、ACH送金、POSシステム連携を含む統合決済ソリューションを提供し、顧客の業務効率化を支援しています。
AORT vs RPAY — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $116.0M | $78.6M |
| 純利益 | $2.4M | $-140.1M |
| 粗利率 | 63.1% | 74.2% |
| 営業利益率 | 9.2% | -182.2% |
| 純利益率 | 2.1% | -178.3% |
| 売上前年比 | 19.2% | 0.4% |
| 純利益前年比 | 114.7% | -3304.1% |
| EPS（希薄化後） | $0.06 | $-1.68 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $116.0M | $78.6M | ||
| Q3 25 | $113.4M | $77.7M | ||
| Q2 25 | $113.0M | $75.6M | ||
| Q1 25 | $99.0M | $77.3M | ||
| Q4 24 | $97.3M | $78.3M | ||
| Q3 24 | $95.8M | $79.1M | ||
| Q2 24 | $98.0M | $74.9M | ||
| Q1 24 | $97.4M | $80.7M |
| Q4 25 | $2.4M | $-140.1M | ||
| Q3 25 | $6.5M | $-6.4M | ||
| Q2 25 | $1.3M | $-102.3M | ||
| Q1 25 | $-505.0K | $-7.9M | ||
| Q4 24 | $-16.5M | $-4.1M | ||
| Q3 24 | $-2.3M | $3.2M | ||
| Q2 24 | $-2.1M | $-4.1M | ||
| Q1 24 | $7.5M | $-5.2M |
| Q4 25 | 63.1% | 74.2% | ||
| Q3 25 | 65.6% | 74.4% | ||
| Q2 25 | 64.7% | 75.7% | ||
| Q1 25 | 64.2% | 75.9% | ||
| Q4 24 | 63.2% | 76.3% | ||
| Q3 24 | 63.7% | 77.8% | ||
| Q2 24 | 64.6% | 78.2% | ||
| Q1 24 | 64.6% | 76.2% |
| Q4 25 | 9.2% | -182.2% | ||
| Q3 25 | 11.1% | -3.9% | ||
| Q2 25 | 7.4% | -138.7% | ||
| Q1 25 | 2.2% | -4.7% | ||
| Q4 24 | 2.7% | -1.5% | ||
| Q3 24 | 4.6% | -0.9% | ||
| Q2 24 | 6.6% | -4.6% | ||
| Q1 24 | 26.0% | -3.1% |
| Q4 25 | 2.1% | -178.3% | ||
| Q3 25 | 5.7% | -8.3% | ||
| Q2 25 | 1.2% | -135.2% | ||
| Q1 25 | -0.5% | -10.3% | ||
| Q4 24 | -16.9% | -5.3% | ||
| Q3 24 | -2.4% | 4.1% | ||
| Q2 24 | -2.2% | -5.4% | ||
| Q1 24 | 7.7% | -6.5% |
| Q4 25 | $0.06 | $-1.68 | ||
| Q3 25 | $0.13 | $-0.08 | ||
| Q2 25 | $0.03 | $-1.15 | ||
| Q1 25 | $-0.01 | $-0.09 | ||
| Q4 24 | $-0.40 | $-0.04 | ||
| Q3 24 | $-0.05 | $0.03 | ||
| Q2 24 | $-0.05 | $-0.04 | ||
| Q1 24 | $0.18 | $-0.06 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $64.9M | $115.7M |
| 総負債低いほど良い | $215.1M | $280.1M |
| 株主資本純資産 | $448.2M | $484.4M |
| 総資産 | $884.8M | $1.2B |
| 負債/資本比率低いほどレバレッジが低い | 0.48× | 0.58× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $64.9M | $115.7M | ||
| Q3 25 | $73.4M | $95.7M | ||
| Q2 25 | $53.5M | $162.6M | ||
| Q1 25 | $37.7M | $165.5M | ||
| Q4 24 | $53.5M | $189.5M | ||
| Q3 24 | $56.2M | $168.7M | ||
| Q2 24 | $55.0M | $147.1M | ||
| Q1 24 | $51.1M | $128.3M |
| Q4 25 | $215.1M | $280.1M | ||
| Q3 25 | $214.9M | $279.5M | ||
| Q2 25 | $215.6M | $279.0M | ||
| Q1 25 | $314.7M | $497.6M | ||
| Q4 24 | $314.3M | $496.8M | ||
| Q3 24 | $314.0M | $496.2M | ||
| Q2 24 | $313.6M | $435.6M | ||
| Q1 24 | $313.3M | $434.9M |
| Q4 25 | $448.2M | $484.4M | ||
| Q3 25 | $438.7M | $616.9M | ||
| Q2 25 | $419.9M | $633.7M | ||
| Q1 25 | $294.3M | $755.7M | ||
| Q4 24 | $276.2M | $761.3M | ||
| Q3 24 | $304.7M | $754.7M | ||
| Q2 24 | $295.1M | $815.4M | ||
| Q1 24 | $295.0M | $813.8M |
| Q4 25 | $884.8M | $1.2B | ||
| Q3 25 | $857.7M | $1.3B | ||
| Q2 25 | $838.4M | $1.4B | ||
| Q1 25 | $791.2M | $1.5B | ||
| Q4 24 | $789.1M | $1.6B | ||
| Q3 24 | $803.1M | $1.6B | ||
| Q2 24 | $789.5M | $1.5B | ||
| Q1 24 | $784.0M | $1.5B |
| Q4 25 | 0.48× | 0.58× | ||
| Q3 25 | 0.49× | 0.45× | ||
| Q2 25 | 0.51× | 0.44× | ||
| Q1 25 | 1.07× | 0.66× | ||
| Q4 24 | 1.14× | 0.65× | ||
| Q3 24 | 1.03× | 0.66× | ||
| Q2 24 | 1.06× | 0.53× | ||
| Q1 24 | 1.06× | 0.53× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $19.6M | $23.3M |
| フリーキャッシュフロー営業CF - 設備投資 | $-7.9M | $23.2M |
| FCFマージンFCF / 売上 | -6.9% | 29.6% |
| 設備投資強度設備投資 / 売上 | 23.7% | 0.1% |
| キャッシュ転換率営業CF / 純利益 | 8.06× | — |
| 直近12ヶ月FCF直近4四半期 | $839.0K | $90.7M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $19.6M | $23.3M | ||
| Q3 25 | $22.3M | $32.2M | ||
| Q2 25 | $15.0M | $33.1M | ||
| Q1 25 | $-17.0M | $2.5M | ||
| Q4 24 | $10.1M | $34.3M | ||
| Q3 24 | $11.5M | $60.1M | ||
| Q2 24 | $6.1M | $31.0M | ||
| Q1 24 | $-5.5M | $24.8M |
| Q4 25 | $-7.9M | $23.2M | ||
| Q3 25 | $17.7M | $32.1M | ||
| Q2 25 | $11.7M | $33.0M | ||
| Q1 25 | $-20.6M | $2.4M | ||
| Q4 24 | $8.7M | $34.0M | ||
| Q3 24 | $7.8M | $59.8M | ||
| Q2 24 | $3.6M | $30.5M | ||
| Q1 24 | $-9.1M | $24.7M |
| Q4 25 | -6.9% | 29.6% | ||
| Q3 25 | 15.6% | 41.3% | ||
| Q2 25 | 10.4% | 43.6% | ||
| Q1 25 | -20.8% | 3.0% | ||
| Q4 24 | 9.0% | 43.5% | ||
| Q3 24 | 8.2% | 75.6% | ||
| Q2 24 | 3.7% | 40.7% | ||
| Q1 24 | -9.3% | 30.6% |
| Q4 25 | 23.7% | 0.1% | ||
| Q3 25 | 4.1% | 0.2% | ||
| Q2 25 | 2.9% | 0.1% | ||
| Q1 25 | 3.7% | 0.2% | ||
| Q4 24 | 1.5% | 0.3% | ||
| Q3 24 | 3.8% | 0.3% | ||
| Q2 24 | 2.6% | 0.6% | ||
| Q1 24 | 3.7% | 0.1% |
| Q4 25 | 8.06× | — | ||
| Q3 25 | 3.42× | — | ||
| Q2 25 | 11.16× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.73× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AORT
| Aortic Stent Grafts | $43.3M | 37% |
| On X | $27.8M | 24% |
| Preservation Services | $24.1M | 21% |
| Surgical Sealants | $20.3M | 18% |
| Other Products | $463.0K | 0% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
